인플루엔자 진단 시장 규모, 점유율 및 성장 분석 : 제품별, 검사별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Influenza Diagnostics Market size was valued at USD 1.14 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 1.55 Billion by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

The growing healthcare expenditure and improved treatment options are contributing to an aging global population, prompting regulatory bodies like the WHO and CDC to diligently compile incidence and prevalence data to combat influenza. Collaborative efforts with local governments aim to enhance disease management and treatment. Initiatives such as the WHO's Global Influenza Program facilitate technical support and strategic guidance for addressing various influenza cases, which is expected to positively influence the Influenza Diagnostics market. However, the market has faced challenges due to the impact of COVID-19, including manufacturing disruptions and regulatory changes affecting diagnostic measures. The similarities between COVID-19 and influenza, particularly in symptomatic presentation, underscore the importance of influenza testing, further driving demand in the diagnostics sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Influenza Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Influenza Diagnostics Market Segments Analysis

Global Influenza Diagnostics Market is segmented by Product, Test, End User and Region. Based on Product, the market is segmented into Test kit and Reagents, Instruments, Other Products. Based on Test, the market is segmented into Molecular Diagnostic Test (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification, Tests), Transcription Mediated Amplification Based Assay, Loop Mediated Isothermal Amplification Based Assay, Nucleic Acid Sequence based Amplification Tests, Traditional Diagnostics Tests (Rapid Influenza Diagnostic Test, Viral Culture Test, Direct Fluorescent Antibody Test, Serological Tests). Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals and Clinics, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Influenza Diagnostics Market

The growing global incidence of influenza has significantly stimulated research and development efforts aimed at enhancing the accuracy of detection and diagnosis methods. A considerable focus within this research is directed towards creating rapid and precise diagnostic tools for influenza viruses, which will consequently propel the growth of the Influenza Diagnostics Market. Furthermore, increased government initiatives to combat outbreaks, coupled with ongoing technological advancements, will also contribute positively to market expansion. Additionally, the rising prevalence of cardiovascular diseases and diabetes is expected to further support the demand for effective influenza diagnostics and drive overall market growth.

Restraints in the Influenza Diagnostics Market

The growth of the Influenza Diagnostics market faces significant challenges due to the shortage of skilled professionals and an inconsistent regulatory environment for the approval of new diagnostic tests. This scarcity of qualified personnel, coupled with inadequate healthcare infrastructure, particularly in developing regions, further complicates the market landscape. These factors not only hinder the effective implementation of diagnostic solutions but also delay innovation and adaptation in response to evolving healthcare needs. As a result, addressing these systemic issues is crucial for fostering a conducive environment for growth and enhancing the overall efficacy of influenza diagnostics.

Market Trends of the Influenza Diagnostics Market

The global influenza diagnostics market is witnessing a notable upward trend driven by a surge in reported influenza cases and a heightened awareness surrounding the importance of early detection and prevention. The rise in influenza incidences highlights the critical need for effective diagnostic solutions, prompting healthcare providers to invest in advanced testing methodologies. Furthermore, the growing emphasis on epidemic preparedness and the implementation of robust healthcare policies are bolstering market demand. As the public becomes increasingly cognizant of the health implications associated with influenza, innovative diagnostic tools are gaining traction, paving the way for substantial market expansion in the foreseeable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Influenza Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Test kit and Reagents
• Instruments
• Others

Influenza Diagnostics Market Size by Test & CAGR (2026-2033)

• Market Overview
• Molecular Diagnostic Test
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification
  • Tests
• Transcription Mediated Amplification Based Assay
• Loop Mediated Isothermal Amplification Based Assay
• Nucleic Acid Sequence based Amplification Tests
• Traditional Diagnostics Tests
• Rapid Influenza Diagnostic Test
• Viral Culture Test
• Direct Fluorescent Antibody Test
• Serological Test

Influenza Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Diagnostic Laboratories
• Hospitals and Clinics
• Others

Influenza Diagnostics Market Size & CAGR (2026-2033)

• North America, (Product, Test, End User)
  • US
  • Canada
• Europe, (Product, Test, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Test, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Test, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Diagnostics, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inverness Medical Innovations, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation